Ai Mediq

Ai Mediq

Intelligent Medical Systems
  • LinkedIn
  • Facebook
  • Reoxy
    • General Description
    • ReOxy Treatment
  • Technology
    • SRT-technology
    • Hypoxia-Hyperoxia Mode
  • IHHT
    • O2 Homeostasis
    • Method overview
    • Physiological effects
    • Applications
  • Support
    • Сustomers Support
    • Resources
  • About us
    • Company
    • Our Partners
    • Contact Us
  • Contact Us

Outcomes

Clinical trial outcomes for rehab after COVID

Author : Petr Golitsyn Date : 13.12.2022

ReOxy therapy and standard rehabilitation has been shown to be as almost twice as effective compared to the standard rehabilitation (83.6 m vs 44.6 m, p<0.001).

Category : News Clinical trial, Conference, COVID-19, Germany, Outcomes Read more

EULAR 2022 Congress

Author : Petr Golitsyn Date : 06.06.2022

The results of the application of ReOxy therapy in patients with osteoarthritis and post-covid syndrome has been demonstrated during the presentation at Eular22

Category : News Cardiac Rehabilitation, Clinical trial, COVID-19, Osteoarthritis, Outcomes, Poster, Rehabilitation Read more
Company Logo
Sitemap
  • REOXY
  • TECHNOLOGY
  • IHHT
  • SUPPORT
  • ABOUT US
  • CONTACT US

Ai Mediq S.A.
Address: 19, rue de Bitbourg,
L-1273 Luxembourg
Luxembourg company code: B155029
VAT number: LU 24203241
Business authorisation: 10039818 / 1

  • LinkedIn
  • Facebook
© 2025 Ai Mediq